https://medsacross.com/pt/guides/avoiding-falsified-medicines 2026-11-13T04:21:17.353Z https://medsacross.com/pt/guides/biosimilars-vs-reference-biologics-in-named-patient-supply 2026-11-13T04:21:17.359Z https://medsacross.com/pt/guides/certificate-of-pharmaceutical-product-copp 2026-11-13T04:21:17.365Z https://medsacross.com/pt/guides/cold-chain-shipping-of-biologics-from-india 2026-11-13T04:21:17.371Z https://medsacross.com/pt/guides/comparator-sourcing-for-clinical-trials 2026-11-13T04:21:17.377Z https://medsacross.com/pt/guides/courier-vs-air-cargo-for-medicines 2026-11-13T04:21:17.383Z https://medsacross.com/pt/guides/expanded-access-compassionate-use-and-named-patient-supply 2026-11-13T04:21:17.388Z https://medsacross.com/pt/guides/how-named-patient-supply-works 2026-11-13T04:21:17.393Z https://medsacross.com/pt/guides/how-to-pay-for-an-international-medicine-order 2026-11-13T04:21:17.399Z https://medsacross.com/pt/guides/how-to-prepare-a-medicine-sourcing-request 2026-11-13T04:21:17.405Z https://medsacross.com/pt/guides/how-to-verify-a-medicine-supplier 2026-11-13T04:21:17.410Z https://medsacross.com/pt/guides/hs-codes-for-medicines 2026-11-13T04:21:17.415Z https://medsacross.com/pt/guides/importing-unlicensed-medicines-into-the-uk 2026-11-13T04:21:17.420Z https://medsacross.com/pt/guides/importing-unregistered-medicines-into-latin-america 2026-11-13T04:21:17.425Z https://medsacross.com/pt/guides/importing-unregistered-medicines-into-russia-and-central-asia 2026-11-13T04:21:17.431Z https://medsacross.com/pt/guides/incoterms-for-pharmaceutical-exports 2026-11-13T04:21:17.436Z https://medsacross.com/pt/guides/indian-export-rules-buyers-should-know 2026-11-13T04:21:17.440Z https://medsacross.com/pt/guides/medicine-pricing-and-lead-times-explained 2026-11-13T04:21:17.445Z https://medsacross.com/pt/guides/nafdac-import-permits-for-unregistered-medicines 2026-11-13T04:21:17.450Z https://medsacross.com/pt/guides/orphan-drug-access-routes 2026-11-13T04:21:17.455Z https://medsacross.com/pt/guides/pharma-export-documents-explained 2026-11-13T04:21:17.459Z https://medsacross.com/pt/guides/section-21-authorisation-south-africa 2026-11-13T04:21:17.465Z https://medsacross.com/pt/guides/shelf-life-requirements-in-medicine-supply 2026-11-13T04:21:17.474Z https://medsacross.com/pt/guides/sourcing-medicines-during-a-shortage 2026-11-13T04:21:17.480Z https://medsacross.com/pt/guides/special-access-routes-in-the-gcc 2026-11-13T04:21:17.487Z https://medsacross.com/pt/guides/temperature-excursions-in-transit 2026-11-13T04:21:17.493Z https://medsacross.com/pt/guides/what-a-pharmacovigilance-report-needs 2026-11-13T04:21:17.499Z https://medsacross.com/pt/guides/who-prequalification-and-donor-funded-tenders 2026-11-13T04:21:17.512Z https://medsacross.com/pt/updates/saudi-sfda-updates-sap-guideline-for-unregistered-medicines 2026-11-13T04:21:17.564Z https://medsacross.com/pt/updates/cdsco-no-separate-export-noc-for-approved-rdna-products-under-export-brand 2026-11-13T04:21:17.532Z https://medsacross.com/pt/updates/india-fema-2026-export-rules-take-effect-with-nine-month-realisation 2026-11-13T04:21:17.546Z https://medsacross.com/pt/updates/nhava-sheva-extends-post-facto-export-noc-relaxation-to-31-december-2026 2026-11-13T04:21:17.551Z https://medsacross.com/pt/updates/india-draft-rule-65-22-would-curb-prescription-drug-advertising-by-licensees 2026-11-13T04:21:17.539Z https://medsacross.com/pt/updates/uk-clinical-trials-regulations-take-effect-28-april-2026 2026-11-13T04:21:17.573Z https://medsacross.com/pt/updates/qatar-requires-two-thirds-shelf-life-on-imported-medicines 2026-11-13T04:21:17.556Z https://medsacross.com/pt/updates/russia-extends-foreign-packaging-regime-for-registered-medicines-to-2027 2026-11-13T04:21:17.559Z https://medsacross.com/pt/updates/cdsco-export-noc-guidance-one-year-noc-and-60-percent-shelf-life-rule 2026-11-13T04:21:17.524Z https://medsacross.com/pt/updates/vietnam-decree-163-2025-replaces-decree-54-for-drug-imports 2026-11-13T04:21:17.583Z